Drugs / sodium dichloroacetate
sodium dichloroacetate
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT00500929 | Jul 2007 → Apr 2008 | heart disorder | Cardiometabolics | Completed | No outcome recorded |
| Phase 2 | NCT00004493 | Sep 1998 → Sep 2003 | lactic acidosis | University of California, San Diego | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00004490 | Oct 1998 → Sep 2002 | lactic acidosis | University of Florida | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sodium dichloroacetate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004490 ↗ |
| Known as | Ceresine | ChEMBL registry synonym — accepted as the source's own label CHEMBL306823 ↗ |
| Known as | CMI X-11S | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00500929 ↗ |
| Known as | CPC-211 | ChEMBL registry synonym — accepted as the source's own label CHEMBL306823 ↗ |
| Known as | DCA | “Determine the pharmacokinetics of sodium dichloroacetate (DCA) in patients with congenital lactic acidemia.” NCT00004493 ↗1“sodium dichloroacetate (DCA) vs placebo” NCT00004490 ↗ |
| Known as | Dca sodium | ChEMBL registry synonym — accepted as the source's own label CHEMBL306823 ↗ |
| Known as | NSC-744479 | ChEMBL registry synonym — accepted as the source's own label CHEMBL306823 ↗ |
| Modality | Small molecule | — CHEMBL306823 ↗ |
| Route | Oral | “DCA and placebo by mouth” NCT00004490 ↗ |